Coronary arteriography and lipid lowering: Limitations, new concepts, and new paradigms in cardiovascular medicine

American Journal of Cardiology

Volumn 82, Issue 6 SUPPL. 1, 1998, Pages

  Gould, K Lance ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LIPID;

ANGIOCARDIOGRAPHY; BLOOD; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; DISEASE COURSE; DRUG EFFECT; HUMAN; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

ANTICHOLESTEREMIC AGENTS; ANTILIPEMIC AGENTS; CHOLESTEROL; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; DISEASE PROGRESSION; HUMANS; LIPIDS; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 0032563779     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00592-X     Document Type: Article

References (86)

1. Brown BG, Zhao XQ, Sacco DE, Albers JJ. Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary artery disease. Circulation 1993;87:1781-1791.
2. Brown GB, Albers JJ, Fisher LD, Schaefer SM, Lin JT, Kaplan CA, Zhao XQ, Bisson BD, Fitzpatrick VF, Dodge HT. Niacin or lovastatin, combined with colestipol regresses coronary atherosclerosis and prevents clinical events in men with elevated apolipoprotein B. N Engl J Med 1990;323:1289-1298.
3. Scandinavian Simvastatin Survival Study (4S). Ramdomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 1994;344: 1383-1389.
4. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hyper-cholesterolemia. N Engl J Med 1995;333:1301-1307.
5. Sacks FM, Pffeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JMO, Wun CC, Davis R, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-1009.
6. Scandinavian Simvastatin Survival Study Group. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S). Lancet 1995;345:1274-1275.
7. Byington RP, Jukema W, Salonen JT, Pitt B, Bruschke AV, Hoen H, Furberg CD, Mancini J. Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the pravastatin atherosclerosis intervention program. Circulation 1995;92:2419-2425.
8. Yusuf S, Anand S. Cost of prevention. The case of lipid lowering. Circulation 1996;93:1774-1776.
9. Herd JA, Ballantyne CM, Farmer JA, Ferguson JJ, Jones PH, West MS, Gould KL, Gotto AM. Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (lipoprotein and coronary atherosclerosis study [LCAS]). Am J Cardiol 1997;80:278-286.
10. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92:657-671.
11. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-2850.
12. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basis mechanisms. Oxidation, inflammation, and genetics. Circulation 1995;91:2488-2496.
13. Navab M, Fogelman AM, Berliner JA, Territo MC, Demer LL, Frank JS, Watson AD, Edwards PA, Lusis AJ. Pathogenesis of atherosclerosis. Am J Cardiol 1995;76(suppl):18C-23C.
14. Farb A, Tang AL, Burke AP, Sessums L, Liang Y, Virmani R. Sudden coronary death. Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation 1995;92:1701-1709.
15. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimai rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
16. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, Fallon JT, Regnstrom J, Fuster V. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation 1995;92:1565-1569.
17. Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995;92:1084-1088.
18. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-318.
19. Richardson PD, Davies MJ, Born GVR. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989; ii:941-944.
20. Smith SC. Risk-reduction therapy: the challenge to change. Circulation 1996;93:2205-2211.
21. Buchwald H, Matts JP, Fitch LL, Campos CT, Sanmarco ME, Amplatz K, Castaneda-Zuniga WR, Hunter DW, Pearce MB, Bissett JK, et al. Changes in sequential coronary arteriograms and subsequent coronary events: program on the Surgical Control of the Hyperlipidemias (POSCH) group. JAMA 1992;268:1429-1433.
22. Waters D, Craven TE, Lesperance J. Prognostic significance of progression of coronary atherosclerosis. Circulation 1993;87:1067-1075.
23. Azen SP, Mack WJ, Cashin-Hemphill L, LaBree L, Shircore AM, Selzer RH, Blankenhorn DH, Hodis HN. Progression of coronary artery disease predicts clinical coronary events. Circulation 1996;93:34-41.
24. Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, Borrico S, Gorlin R, Fuster V. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol 1988;12:56-62.
25. Chen L, Chester MR, Crook R, Kaski JC. Differential progression of complex culprit stenoses in patients with stable and unstable angina pectoris. J Am Coll Cardiol 1996;28:597-603.
26. Gould KL. Coronary Artery Stenosis and Reversing Heart Disease, 2nd ed. New York: Lippincott-Raven Press, 1998.
27. Fleming RM, Kirkeeide RL, Smalling RW, Gould KL, Stuart Y. Patterns in visual interpretation of coronary arteriograms as detected by quantitative coronary arteriography. J Am Coll Cardiol 1991;18:945-951.
28. Rensing BJ, Hermans WRM, Beatt KJ, Laarman GJ, Suryapranata H, van den Brand M, De Feyter PJ, Serruys PW. Quantitative angiographic assessment of elastic recoil after percutaneous transluminal coronary angioplasty. Am J Cardiol 1990;66:1039-1044.
29. Mintz GS, Painter JA, Pichard AD, Kent KM, Satler LF, Popma JJ, Chuang YC, Bucher TA, Sokolowicz LE, Leon MB. Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 1995;25:1479-1485.
30. Tuzcu EM, Hobbs RE, Rincon G, Bott-Silverman C, De Franco AC, Robinson Killian McCarthy PM, Stewart RW, Guyer S, Nissen SE. Occult and frequent transmission of atherosclerotic coronary disease with cardiac transplantation. Insights from intravascular ultrasound. Circulation 1995;91:1706-1713.
31. Tuzcu EM, De Franco AC, Goormastic M, Hobbs RE, Rincon G, Bott-Silverman C, McCarthy P, Stewart R, Mayer E, Nissen SE. Dichotomous pattern of coronary atherosclerosis 1 to 9 years after transplantation: insights from systematic intravascular ultrasound imaging. J Am Coll Cardiol 1996;27:837-846.
32. Hausmann D, Johnson JA, Sudhir K, Mullen WL, Friedrich G, Fitzgerald PJ, Chou TM, Ports TA, Kane JP, Mallow MJ, Yock PG. Angiographically silent atherosclerosis detected in intravascular ultrasound in patients with familial hypercholesterolemia and familial combined hyperlipidemia: correlation with high density lipoproteins. J Am Coll Cardiol 1996;27:1562-1570.
33. Little WC, Downes TR, Applegate RJ. The underlying coronary lesion in myocardial infarction: implications for coronary angiography. Clin Cardiol 1991; 14:868-874.
34. Cianflone D, Ciccirillo F, Buffon A, Trani C, Scabbia EV, Finocchiaro ML, Crea F. Comparison of coronary angiographic narrowing in stable angina pectoris, unstable angina pectoris, and in acute myocardial infarction. Am J Cardiol 1995;76:215-219.
35. Little WC, Braden G, Applegate RJ. Angiographic evaluation of the extent and progression of coronary artery disease: limitations of lumenology. Council Newsletter. Clin Cardiol Spring 1995. Ed. BJ Gersh.
36. Seiler C, Kirkeeide RL, Gould KL. Basic structure-function relations of the epicardial vascular tree: the basis of quantitative coronary arteriography for diffuse coronary artery disease. Circulation 1992;85:1987-2003.
37. Seiler C, Kirkeeide RL, Gould KL. Measurement from arteriograms of regional myocardial bed size distal to any point in the coronary arterial tree for assessing anatomic area at risk. J Am Coll Cardiol 1993;21:783-797.
38. Nishioka T, Luo H, Eigler NL, Berglund H, Kim CJ, Siegel RJ. Contribution of inadequate compensatory enlargement to development of human coronary artery stenosis: an in vivo intravascular ultrasound study. J Am Coll Cardiol 1996;27:1571-1576.
39. Armstrong ML, Heistad DD, Marcus ML, Megan MB, Piegors DJ. Structural and hemodynamic responses of peripheral arteries of macaque monkeys to atherogenic diet. Arteriosclerosis 1985;5:336-346.
40. Glagov S, Weisenberg E, Zarins CK, Stankunacicius K, Kolettis GJ. Compensatory enlargement of various human atherosclerotic arteries. N Engl J Med 1987;316:1371-1375.
41. Kern MJ, Donohue TJ, Bach RG, Caracciolo EA, Flynn MS, Aguirre FV. Clinical applications of the Doppler coronary flow velocity guidewire for interventional procedures. J Intervent Cardiol 1993;6:345-363.
42. Fedele FA, Sharaf B, Most AS, Gewirtz H. Details of coronary stenosis morphology influence its hemodynamic severity and distal flow reserve. Circulation 1989;80:636-642.
43. Ofili EO, Labovitz AJ, Kern MJ. Coronary flow velocity dynamics in normal and diseased arteries. Am J Cardiol 1993;71(suppl):3D-9D.
44. Voudris V, Manginas A, Vassilikos V, Koutelou M, Kantzis J, Cokkinos DV. Coronary flow velocity changes after intravenous dipyridamole infusion: measurements using intravascular Doppler guide wire. A documentation of flow inhomogeneity. J Am Coll Cardiol 1996;27:1148-1155.
45. Kern MJ, Andersen HV. A symposium. The clinical applications of the intracoronary Doppler guidewire flow velocity in patients: understanding blood flow beyond the coronary stenosis. Am J Cardiol 1993;71(suppl):1D-70D.
46. Kern MJ, Donohue TJ, Aguirre FV, Bach RG, Caracciolo EA, Ofili E, Labovitz AJ. Assessment of angiographically intermediate coronary artery stenosis using the Doppler flowire. Am J Cardiol 1993;71(suppl):26D-33D.
47. Zijlstra F, Reiber JC, Juilliere Y, Serruys PW. Normalization of coronary flow reserve by percutaneous transluminal coronary angioplasty. Am J Cardiol 1988;61:55-60.
48. Miller DD, Donohue TJ, Younis LT, Bach RG, Aguirre FV, Wittry MD, Goodgold HM, Chaitman BR, Kern MJ. Correlation of pharmacological 99m Tcsestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses. Circulation 1994;89:2150-2160.
49. Joye JD, Schulman DS, Lasorda D, Farah T, Donohue BC, Reichek N. Intracoronary Doppler guide wire versus stress single photon emission tomographic thallium-201 imaging in assessment of intermediate coronary stenoses. J Am Coll Cardiol 1994;24:940-947.
50. Tron C, Donohue TJ, Bach RG, Aguirre FV, Caracciolo EA, Wolford TL, Miller DD, Kern MJ. Comparison of pressure-derived fractional flow reserve with poststenotic coronary flow velocity reserve for prediction of stress myocardial perfusion imaging results. Am Heart J 1995;130:723-733.
51. Donohue TJ, Miller DD, Bach RG, Tron C, Wolford T, Caracciolo EA, Aguirre FV, Younis LT, Chaitman BR, Kern MJ. Correlation of poststenotic hyperemic coronary flow velocity and pressure with abnormal stress myocardial perfusion imaging in coronary artery disease. Am J Cardiol 1996;77:948-954.
52. Serruys PW, de Mario C, Meneveau N, de Jaegere P, Strikwerda S, de Feyter PJ, Emanuelsson H. Intracoronary pressure and flow velocity from sensor tip guidewire: a new methodical comprehensive approach for the assessment of coronary hemodynamics before and after interventions. Am J Cardiol 1993; 71(suppl):41D-53D.
53. Wilson RF, Johnson MR, Marcus ML, Aylward PEG, Skorton DJ, Collins S, White CW. The effect of coronary angioplasty on coronary flow reserve. Circulation 1988;77:873-885.
54. Ofili EO, Kern MJ, Labovitz AJ, St Vrain JA, Segal J, Aguirre FV, Castello R. Analysis of coronary blood flow velocity dynamics in angiographically normal and stenosed arteries before and after endoluminal enlargement by angioplasty. J Am Coll Cardiol 1993;21:308-316.
55. Nanto S, Kodama K, Hori M, Mishima M, Hirayama A, Inoue M, Kanada T. Temporal increase in resting coronary blood flow causes an impairment of coronary flow reserve after coronary angioplasty. Am Heart J 1992;123:28-36.
56. Anderson HV, Kirkeeide RL, Stuart Y, Smalling RW, Heibig J, Willerson JT. Coronary artery flow monitoring following coronary interventions. Am J Cardiol 1993;71(suppl):62D-69D.
57. Segal J. Applications of coronary flow velocity during angioplasty and other coronary interventional procedures. Am J Cardiol 1993;71(suppl):17D-25D.
58. Kern MJ, Donohue TJ, Bach RG, Aguirre FV, Caracciolo EA, Ofili EO. Quantitating coronary collateral flow velocity in patients during coronary angioplasty using a Doppler guidewire. Am J Cardiol 1993;71(suppl):34D-40D.
59. Gould KL. Pressure-flow characteristics of coronary stenoses in intact unsedated dogs at rest and during coronary vasodilation. Circ Res 1978;43:242-253.
60. Gould KL, Kelley KO. Significance of coronary flow velocity and changing stenosis geometry during coronary vasodilation in awake dogs. Circ Res 1982; 50:695-704.
61. Gould KL, Kelley KO. Experimental validation of quantitative coronary arteriography for determining pressure-flow characteristics of coronary stenoses. Circulation 1982;66:930-937.
62. Kirkeeide RL, Gould KL, Parsel L. Assessment of coronary stenoses by myocardial imaging during coronary vasodilation, VII: validation of coronary flow reserve as a single integrated measure of stenosis severity accounting for all its geometric dimensions. J Am Coll Cardiol 1986;7:103-113.
63. Gould KL, Kirkeeide RL, Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. I. Relative and absolute coronary flow reserve during changing aortic pressure and cardiac workload. II. Determination from arteriographic stenosis dimensions under standardized conditions. J Am Coll Cardiol 1990;15:459-474.
64. Gould KL, Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 1974;34:48-55.
65. Pijls NHJ, van Son AM, Kirkeeide RL, de Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurement for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993;87: 1354-1367.
66. De Bruyne B, Baudhuin T, Melin JA, Pijls NHJ, Sys SU, Boll A, Paulus WJ, Heyndricks GR, Wijns W. Coronary flow reserve calculated from pressure measurements in humans: validation with positron emission tomography. Circulation 1994;89:1013-1022.
67. Pijls NHJ, Van Gelder B, Van der Voort P, Peels K, Bracke FALE, Bonier HJRM, El Gamal MIH. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 1995;92:3183-3193.
68. Pijls NHJ, Bech GJW, El Gamal MIH, Bonnier JJRM, de Bruyne B, Van Gelder B, Michels HR, Kooken JJ. Quantification of recruitable coronary collateral blood flow in conscious man and its potential to predict future ischemic events. J Am Coll Cardiol 1995;25:1522-1528.
69. Pijls NHJ, De Bruyne B, El Gamal M, Bonnier HJRM, Heyndrickx GR, Bech GJW, Koolen JJ, Michels HR, Bracke FALE, Wijns W. Fractional flow reserve: the ideal parameter for evaluation of coronary, myocardial, and collateral blood flow by pressure measurements at PTCA. J Intervent Cardiol 1993;6:331-344.
70. De Bruyne B, Meier B, Finci L, Urban P, Rutishauser W. Potential protective effect of high coronary wedge pressure on left ventricular function after coronary occlusion. Circulation 1988;78:566-572.
71. Pijls NHJ, de Bruyne B, Peels K, van der Voort PH, Bonnier HJRM, Bartunek J, Koolen JJ. Measurement of fractional flow reserve to assess the functional severity of coronary artery stenoses. N Engl J Med 1996;334:1703-8.
72. De Bruyne B, Bartunek J, Sys S, Heyndrickx GR. Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia. Circulation 1995;92:39-46.
73. Gould KL. Reversal of coronary atherosclerosis: clinical promise as the basis for the non-invasive management of coronary artery disease. Circulation 1994; 90:1558-1571.
74. Nakagawa Y, Gould KL. Longitudinal base to apex perfusion gradients by dipyridamole positron emission tomography indicate diffuse coronary atherosclerosis. (Abstr.) Circulation 1996;94(suppl I):I-602.
75. Gould K, Ornish D, Scherwitz L, Brown S, Edens RP, Hess MJ, Mullani N, Bolomey L, Dobbs F, Armstrong WT, Merritt T, Ports T, Sparler S, Billings J. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA 1995;274:894-901.
76. Gould KL, Martucci JP, Goldberg DI, Hess MJ, Edens RP, Latifi R, Dudrick SJ. Short-term cholesterol lowering decreases in size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. Circulation 1994;89:1530-1538.
77. Czernin J, Barnard J, Sun KT, Krivokapich J, Nitzsche E, Dorsey D, Phelps ME, Schelbert HR. Effects of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve. Circulation 1995;92:197-204.
78. Schuler G, Hambrecht R, Schlerf G, Grunze M, Methfessel S, Hauer K, Kubler W. Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet. J Am Coll Cardiol 1992;19:34-42.
79. Eichstadt HW, Eskotter H, Hoffman I, Amthauer HW, Weidinger G. Improvement of myocardial perfusion by short term fluvastatin therapy in coronary artery disease. Am J Cardiol 1995;76(suppl):122A-124A.
80. De Mario C, de Feyter PJ, Slager CJ, de Jaegere P, Roelandt JRTC, Serruys PW. Intracoronary blood flow velocity and trans-stenotic pressure gradient using sensory-tip pressure and Doppler guidewires. Cathet Cardiovasc Diagn 1993;28: 311-319.
81. Gould KL, Lipscomb K, Hamilton GW. A physiologic basis for assessing critical coronary stenosis: instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 1974;33:87-94.
82. Gould KL. Noninvasive assessment of coronary stenoses by myocardial imaging during coronary vasodilation. I. Physiologic principles and experimental validation. Am J Cardiol 1978;41:267-278.
83. Gould KL, Westcott JR, Hamilton GW. Noninvasive assessment of coronary stenoses by myocardial imaging during coronary vasodilation. II. Clinical methodology and feasibility. Am J Cardiol 1978;41:279-289.
84. Albro PC, Gould KL, Westcott RJ, Hamilton GW, Ritchie JL, Williams DL. Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. III. Clinical trial. Am J Cardiol 1978;42: 751-760.
85. Gould KL. Assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilatation. IV. Limits of stenosis detection by idealized, experimental, cross-sectional myocardial imaging. Am J Cardiol 1978;42:761-768.
86. Gould KL, Schelbert H, Phelps M, Hoffman E. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. V. Detection of 47% diameter coronary stenosis with intravenous 13NH4- and emission computer tomography in intact dogs. Am J Cardiol 1979;43:200-208.